Seminar TRR 374: Therapeutic Antisense Oligonucleotides: A Maturing Technology Expanding the Universe of Targetable Drug Targets

Date: 20. January 2025Time: 13:00 – 14:00Location: Dr. Frank Jaschinski, CSO Secarna Pharmaceuticals | Hybrid

Seminar TRR 374: Therapeutic Antisense Oligonucleotides: A Maturing Technology Expanding the Universe of Targetable Drug Targets

Dr. Frank Jaschinski, CSO Secarna Pharmaceuticals GmbH & Co. KG, Martinsried

Time: Monday, January 20, 2025; 13:00h

Location: Seminarraum Physiologie VKL 4.1.29 Universität Regensburg and Zoom

To get the Zoom link please contact: michaela.kritzenberger@ur.de

Add to calendar

Event Details

Date:
20. January 2025
Time:
13:00 – 14:00
Location:

Dr. Frank Jaschinski, CSO Secarna Pharmaceuticals | Hybrid

Event Categories:
Gastsprecherseminar